脑出血后继发性脑损伤的机制与治疗

doi:10.3969/j.issn.1673-5765.2019.02.020

摘要/Abstract

摘要：

脑出血具有高发病率和高死亡率的特点。近年研究表明，脑出血产生的继发性脑损伤机制主要涉及凝血酶诱导、红细胞裂解、毒性反应、氧化损伤和炎症反应等多个方面。根据不同的损伤机制，应运而生了多种脑出血的治疗策略，但是否能成功应用于临床还有待进一步研究。本文对脑出血后继发性损伤的潜在机制和新兴治疗方法进行了综述。

文章导读： 本文综述了脑出血后继发性损伤的潜在机制和治疗策略，为脑出血治疗的进一步研究提供参考。

关键词: 脑出血; 继发性脑损伤; 损伤机制; 治疗

Abstract:

Intracerebral hemorrhage (ICH) has high mortality and morbidity. Recent studies have shown that the mechanism of secondary brain injury caused by ICH mainly involves the thrombin-induced injury, red blood cell lysis, toxic reaction, oxidative injury, inflammation and so on. According to different injury mechanism, several emerging therapeutic strategies for cerebral hemorrhage have developed. However, there are few therapies that can be successfully applied in clinic, which need to be further studied. This article mainly reviewed the potential mechanism and the emerging treatment methods of secondary brain injury after ICH.

Key words: Intracerebral hemorrhage; Secondary brain injury; Injury mechanism; Therapeutic method

朱燕，朱东亚. 脑出血后继发性脑损伤的机制与治疗[J]. 中国卒中杂志, 2019, 14(02): 183-187.

ZHU Yan, ZHU Dong-Ya. Mechanism and Treatment of Secondary Brain Injury after Intracerebral Hemorrhage[J]. Chinese Journal of Stroke, 2019, 14(02): 183-187.

参考文献

[1] URDAY S，KIMBERLY W T，BESLOW L A，et

al. Targeting secondary injury in intracerebral

haemorrhage--perihaematomal oedema[J]. Nat Rev

Neurol，2015，11（2）：111-122.

[2] STEINER T，ROSAND J，DIRINGER M.

Intracerebral hemorrhage associated with oral

anticoagulant therapy：current practices and

unresolved questions[J]. Stroke，2006，37（1）：256-

262.

[3] WEST K L，ADAMSON C，HOFFMAN M.

Prophylactic correction of the international

normalized ratio in neurosurgery：a brief review of a

brief literature：a review[J]. J Neurosurq，2011，114

（1）：9-18.

[4] HUA Y，KEEP R F，HOFF J T，et al. Brain

injury after intracerebral hemorrhage：the role

of thrombin and iron[J/OL]. Stroke，2007，38（2

Suppl）：759-762. https：//doi.org/10.1161/01.

STR.0000247868.97078.10.

[5] HOLLENBERG M D，COMPTON S J. International

union of pharmacology. XXVIII. Proteinaseactivated

receptors[J]. Pharmacol Rev，2002，54（2）：

203-217.

[6] YANG Y，ZHANG M，KANG X，et al. Thrombininduced

microglial activation impairs hippocampal

neurogenesis and spatial memory ability in mice[J].

Behav Brain Functi，2015，11（1）：30.

[7] BABU R，BAGLEY J H，DI C，et al. Thrombin

and hemin as central factors in the mechanisms of

intracerebral hemorrhage–induced secondary brain

injury and as potential targets for intervention[J/OL].

Neurosurg Focus，2012，32（4）：E8. https：//doi.

org/10.3171/2012.1.FOCUS11366.

[8] ZHENG H，CHEN C，ZHANG J，et al. Mechanism

and therapy of brain edema after intracerebral hemorrhage[J]. Cerebrovasc Dis，2016，42（3-4）：

155-169.

[9] XI G，KEEP R F，HOFF J T. Erythrocytes

and delayed brain edema formation following

intracerebral hemorrhage in rats[J]. J Neurosurg，

1998，89（6）：991-996.

[10] MIN H，CHOI B，JANG Y H，et al. Heme molecule

functions as an endogenous agonist of astrocyte

TLR2 to contribute to secondary brain damage after

intracerebral hemorrhage[J]. Mol Brain，2017，10（1）：

27.

[11] XIONG X Y，WANG J，QIAN Z M，et al. Iron

and intracerebral hemorrhage：from mechanism to

translation[J]. Trans Stroke Res，2014，5（4）：429-

441.

[12] XI G，KEEP R F，HOFF J T. Mechanisms of brain

injury after intracerebral haemorrhage[J]. Lancet

Neurol，2006，5（1）：53-63.

[13] CHEN-ROETLING J，LU X，REGAN R F.

Targeting heme oxygenase after intracerebral

hemorrhage[J/OL]. Ther Targets Neuro Dis，2015，2

（1）. pii：474. https：//doi.org/10.14800/ttnd.474.

[14] QURESHI A I，ALI Z，SURI M F K，et al.

Extracellular glutamate and other amino acids in

experimental intracerebral hemorrhage：an in vivo

microdialysis study[J]. Crit Care Med，2003，31（5）：

1482-1489.

[15] DUAN Z Z，ZHANG F，LI F Y，et al. Protease

activated receptor 1（PAR1）enhances Src-mediated

tyrosine phosphorylation of NMDA receptor in

intracerebral hemorrhage（ICH）[J/OL]. Sci Rep，

2016，6：29246. https：//doi.org/10.1038/srep29246.

[16] HU X，TAO C，GAN Q，et al. Oxidative stress in

intracerebral hemorrhage：sources，mechanisms，

and therapeutic targets[J/OL]. Oxid Med Cell

Longev，2016，2016：3215391. https：//doi.

org/10.1155/2016/3215391.

[17] ZHAO X，ARONOWSKI J. Nrf2 to pre-condition

the brain against injury caused by products of

hemolysis after ICH[J]. Transl Stroke Res，2013，4

（1）：71-75.

[18] YU Y P，CHI X L，LIU L J. A hypothesis：

hydrogen sulfide might be neuroprotective against

subarachnoid hemorrhage induced brain injury[J/

OL]. Scientific World Journal，2014，2014：432318.

https：//doi.org/10.1155/2014/432318.

[19] DUAN X，WEN Z，SHEN H，et al. Intracerebral

hemorrhage，oxidative stress，and antioxidant

therapy[J/OL]. Oxid Med Cell Longev，2016，2016：

1203285. https：//doi.org/10.1155/2016/1203285.

[20] ZHOU Y，WANG Y，WANG J，et al. Inflammation

in intracerebral hemorrhage：from mechanisms

to clinical translation[J/OL]. Prog Neurobiol，

2014，115：25-44. https：//doi.org/10.1016/

j.pneurobio.2013.11.003.

[21] ZHANG Z，ZHANG Z，LU H，et al. Microglial

polarization and inflammatory mediators after

intracerebral hemorrhage[J]. Mol Neurobiol，2017，

54（3）：1874-1886.

[22] ARONOWSKI J，ZHAO X. Molecular

pathophysiology of cerebral hemorrhage：secondary

brain injury[J]. Stroke，2011，42（6）：1781-1786.

[23] SUN Z，ZHAO Z，ZHAO S，et al. Recombinant

hirudin treatment modulates aquaporin-4 and

aquaporin-9 expression after intracerebral

hemorrhage in vivo[J]. Mol Biol Rep，2009，36（5）：

1119.

[24] ZHOU Z H，QU F，ZHANG C D. Systemic

administration of argatroban inhibits proteaseactivated

receptor-1 expression in perihematomal

tissue in rats with intracerebral hemorrhage[J]. Brain

Res Bull，2011，86（3-4）：235-238.

[25] NAKAMURA T，KURODA Y，HOSOMI N，et al.

Serine protease inhibitor attenuates intracerebral

hemorrhage-induced brain injury and edema

formation in rat[J/OL]. Acta Neurochir Suppl，2010，

106：307-310. https：//doi.org/10.1007/978-3-211-

98811-4_57.

[26] CUI H J，HE H，YANG A L，et al. Efficacy of

deferoxamine in animal models of intracerebral

hemorrhage：a systematic review and stratified metaanalysis[

J/OL]. PloS One，2015，10（5）：e0127256.

https：//doi.org/10.1371/journal.pone.0127256.

[27] ZENG L，TAN L，LI H，et al. Deferoxamine therapy

for intracerebral hemorrhage：A systematic review[J/

OL]. PloS One，2018，13（3）：e0193615. https：//doi.

org/10.1371/journal.pone.0193615.

[28] WU H，WU T，XU X，et al. Iron toxicity in

mice with collagenase-induced intracerebral

hemorrhage[J]. J Cereb Blood Flow Metab，2011，31

（5）：1243-1250.

[29] NAKAMURA T，KEEP R F，HUA Y，et al.

Deferoxamine-induced attenuation of brain

edema and neurological deficits in a rat model of

intracerebral hemorrhage[J]. J Neurosurg，2004，100

（4）：672-678.

[30] YU Y，ZHAO W，ZHU C，et al. The clinical

effect of deferoxamine mesylate on edema after

intracerebral hemorrhage[J/OL]. PLoS One，2015，

10（4）：e0122371. https：//doi.org/10.1371/journal.

pone.0122371.

[31] LI Q，WAN J，LAN X，et al. Neuroprotection of brain-permeable iron chelator VK-28 against

intracerebral hemorrhage in mice[J]. J Cereb Blood

Flow Metab，2017，37（9）：3110-3123.

[32] BELUR P K，CHANG J J，HE S，et al. Emerging

experimental therapies for intracerebral hemorrhage：

targeting mechanisms of secondary brain injury[J/

OL]. Neurosurg Focus，2013，34（5）：E9. https：//

doi.org/10.3171/2013.2.FOCUS1317.

[33] WASSERMAN J K，ZHU X，SCHLICHTER L C.

Evolution of the inflammatory response in the brain

following intracerebral hemorrhage and effects

of delayed minocycline treatment[J/OL]. Brain

Res，2007，1180：140-154. https：//doi.org/10.1016/

j.brainres.2007.08.058.

[34] WU Z，ZOU X，ZHU W，et al. Minocycline is

effective in intracerebral hemorrhage by inhibition

of apoptosis and autophagy[J/OL]. J Neurol Sci，2016，

371：88-95. https：//linkinghub.elsevier.com/retrieve/

pii/S0022510X16306645.

[35] CAO S，HUA Y，KEEP R F，et al. Minocycline

effects on intracerebral hemorrhage-induced iron

overload in aged rats：brain iron quantification with

magnetic resonance imaging[J]. Stroke，2018，49（4）：

995-1002.

[36] SZYMANSKA A，BIERNASKIE J，LAIDLEY

D，et al. Minocycline and intracerebral hemorrhage：

influence of injury severity and delay to treatment[J].

Exp Neurol，2006，197（1）：189-196.

[37] SALIBA W，RENNERT H S，BARNETTGRINESS

O，et al. Association of statin use with

spontaneous intracerebral hemorrhage：A cohort

study[J/OL]. Neurology，2018，91（5）：e400-e409.

https：//doi.org/10.1212/WNL.0000000000005907.

[38] YANG D，KNIGHT R A，HAN Y，et al. Vascular

recovery promoted by atorvastatin and simvastatin

after experimental intracerebral hemorrhage：

magnetic resonance imaging and histological study.

Laboratory investigation[J]. J Neurosurg，2011，114

（4）：1135-1142.

[39] TAPIA-PEREZ H，SANCHEZ-AGUILAR M，

TORRES-CORZO J G，et al. Use of statins for the

treatment of spontaneous intracerebral hemorrhage：

results of a pilot study[J]. Cent Eur Neurosurg，2009，

70（1）：15-20.

[40] PAN Y S，JING J，WANG Y L，et al. Use of statin

during hospitalization improves the outcome after

intracerebral hemorrhage[J]. CNS Neurosci Ther，

2014，20（6）：548-555.

[41] KAWAI N，KAWANISHI M，OKAUCHI M，et al.

Effects of hypothermia on thrombin-induced brain

edema formation[J]. Brain Res，2001，895（1-2）：

50-58.

[42] KAWANISHI M，KAWAI N，NAKAMURA T，et

al. Effect of delayed mild brain hypothermia on

edema formation after intracerebral hemorrhage in

rats[J]. J Stroke Cerebrovasc Dis，2008，17（4）：187-

195.

[43] SONG F，GUO C，GENG Y，et al. Therapeutic

time window and regulation of autophagy by mild

hypothermia after intracerebral hemorrhage in rats[J/

OL]. Brain Res，2018，1690：12-22. https：//doi.

org/10.1016/j.brainres.2018.04.005.

[44] STAYKOV D，WAGNER I，VOLBERS B，et al.

Mild prolonged hypothermia for large intracerebral

hemorrhage[J]. Neurocrit Care，2013，18（2）：178-

183.